Home002773 • SHE
add
Chengdu Kanghong Pharma Grp Co Ltd
Previous close
¥27.93
Day range
¥27.55 - ¥28.50
Year range
¥16.62 - ¥29.46
Market cap
25.67B CNY
Avg Volume
13.79M
P/E ratio
21.49
Dividend yield
1.36%
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.20B | 9.70% |
Operating expense | 622.89M | 13.69% |
Net income | 400.02M | 7.09% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 507.93M | 4.67% |
Effective tax rate | 14.30% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.08B | 20.00% |
Total assets | 9.67B | 9.50% |
Total liabilities | 627.52M | -3.45% |
Total equity | 9.05B | — |
Shares outstanding | 919.87M | — |
Price to book | 2.84 | — |
Return on assets | — | — |
Return on capital | 12.73% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 400.02M | 7.09% |
Cash from operations | 433.08M | 6.69% |
Cash from investing | -2.69B | -34.16% |
Cash from financing | -1.21M | -1,025.44% |
Net change in cash | -2.26B | -41.20% |
Free cash flow | 143.20M | 11.91% |
About
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. It was founded in 1996 and researches, develops, manufactures, and distributes medicines for ophthalmic, central nervous, digestive and endocrine systems. The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion.
As of May 2021, the company had 18 drugs on the market including Lumitin. Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona, Bolexin and Bosiqing, Yitaning, Shugan Jieyu, Danshu, and Yiqing. Kanghong also currently has 13 subsidiaries in China, Israel, and the United States. Wikipedia
Founded
Oct 3, 1996
Website
Employees
4,462
